tiprankstipranks
Tango Therapeutics (TNGX)
NASDAQ:TNGX
US Market

Tango Therapeutics (TNGX) Income Statement

Compare
308 Followers

Tango Therapeutics Income Statement

Last quarter (Q3 2024), Tango Therapeutics's total revenue was $11.61M, an increase of 8.15% from the same quarter last year. In Q3, Tango Therapeutics's net income was $-29.17M. See Tango Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 36.53M$ 24.86M$ 37.04M$ 7.66M$ 24.65M
Gross Profit
$ -78.67M$ 20.83M$ 35.08M$ 6.03M$ -7.63M
Operating Expenses
$ 150.70M$ 135.93M$ 95.23M$ 59.86M$ 7.15M
Depreciation and Amortization
$ 2.42M$ 4.03M$ 1.97M$ 1.63M$ 643.00K
EBITDA
$ -111.76M$ -109.46M$ -57.29M$ -51.48M$ -14.52M
Operating Income
$ -114.17M$ -111.07M$ -58.19M$ -52.20M$ -15.16M
Other Income/Expenses
$ 12.56M$ 2.95M$ 247.00K$ 228.00K$ 1.07M
Pretax Income
$ -101.61M$ -108.12M$ -57.94M$ -51.97M$ -14.10M
Net Income
$ -101.74M$ -108.18M$ -58.23M$ -51.86M$ -14.10M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.08$ -1.23$ -0.94$ -1.62$ -1.57
Diluted EPS
$ -1.08$ -1.23$ -0.94$ -1.62$ -1.57
Weighted Average Shares Outstanding
94.57M 87.82M 62.11M 31.93M 8.99M
Weighted Average Shares Outstanding (Diluted)
94.57M 87.82M 62.11M 31.93M 8.99M
Currency in USD

Tango Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis